Viatris
$12.94
24H
Market Cap
Volume
Supply
Price Chart
About Viatris - VTRS
Viatris Inc. is a global healthcare company formed through the merger of Mylan N.V. and Upjohn, a division of Pfizer, which focuses on the production and distribution of generic and specialty pharmaceuticals, as well as over-the-counter medications. The company's mission is to provide access to affordable medications to patients around the world.
What are Viatris's core values and mission statement?
Viatris Inc.'s core values are centered on empowering people worldwide to live healthier lives by expanding access to medicines and healthcare services. Their mission statement emphasizes a commitment to providing patients around the globe with access to high-quality, trusted medicines and healthcare services at every stage of life.
Who founded Viatris and when?
Viatris Inc. was founded in 2019 following the merger of Mylan N.V. and Upjohn, a division of Pfizer.
Who leads Viatris?
As of the last available information, Michael Goettler was serving as the CEO of Viatris Inc.
Where is Viatris located, and what is its base country?
Viatris Inc. is headquartered in Canonsburg, Pennsylvania, United States, and its base country is the United States.
On which exchanges is Viatris traded?
Viatris Inc. is traded on the Nasdaq Stock Market under the ticker symbol VTRS.
Historical data
Viatris (VTRS) Price Live Data
The live price of Viatris (VTRS) is $12.94, with a trading volume of 6,633,078 in the last 24 hours. Wrapstocks updates the VTRS price in real-time. Viatris is down -1.86% in the last 24 hours. The company has a live market cap of $15,439,087,616.00 and a supply of 1,193,590,075 VTRS stocks.
Viatris (VTRS) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 2 hours and 26 minutes.
